Elder Pharma weighs sale of nutrition business: Sources

However, Joint MD denies development

Drugmaker is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.

One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.

However, Elder Pharma Alok Saxena denied that the company was looking to sell the business.

"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.

The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about $1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.

A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.

Last year, French drugmaker Sanofi's India unit Aventis Pharma acquired the nutrition business of Universal Medicare for about 5 billion rupees while Danone agreed to buy the baby nutrition business of India's Wockhardt for $355 million.

U.S. drugmaker Abbott Laboratories last week agreed to set up a research and development centre with India's Biocon to develop affordable nutrition products for the domestic market.

"The talks are only at consideration stage and this business is a small division for Elder," a second source said.

Both sources declined to be identified because the matter is private.

sells the popular nutritional products such as multi-vitamin tablets Eldervit, kidney dietary supplement drug Nephrocaps and Elmecob, a tablet used to support anemia treatment.

image
Business Standard
177 22
Business Standard

Elder Pharma weighs sale of nutrition business: Sources

However, Joint MD denies development

Reuters  |  Mumbai 



Drugmaker is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.

One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.



However, Elder Pharma Alok Saxena denied that the company was looking to sell the business.

"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.

The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about $1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.

A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.

Last year, French drugmaker Sanofi's India unit Aventis Pharma acquired the nutrition business of Universal Medicare for about 5 billion rupees while Danone agreed to buy the baby nutrition business of India's Wockhardt for $355 million.

U.S. drugmaker Abbott Laboratories last week agreed to set up a research and development centre with India's Biocon to develop affordable nutrition products for the domestic market.

"The talks are only at consideration stage and this business is a small division for Elder," a second source said.

Both sources declined to be identified because the matter is private.

sells the popular nutritional products such as multi-vitamin tablets Eldervit, kidney dietary supplement drug Nephrocaps and Elmecob, a tablet used to support anemia treatment.

RECOMMENDED FOR YOU

Elder Pharma weighs sale of nutrition business: Sources

However, Joint MD denies development

Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.

Drugmaker is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.

One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.

However, Elder Pharma Alok Saxena denied that the company was looking to sell the business.

"We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters.

The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about $1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry.

A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.

Last year, French drugmaker Sanofi's India unit Aventis Pharma acquired the nutrition business of Universal Medicare for about 5 billion rupees while Danone agreed to buy the baby nutrition business of India's Wockhardt for $355 million.

U.S. drugmaker Abbott Laboratories last week agreed to set up a research and development centre with India's Biocon to develop affordable nutrition products for the domestic market.

"The talks are only at consideration stage and this business is a small division for Elder," a second source said.

Both sources declined to be identified because the matter is private.

sells the popular nutritional products such as multi-vitamin tablets Eldervit, kidney dietary supplement drug Nephrocaps and Elmecob, a tablet used to support anemia treatment.

image
Business Standard
177 22
Widgets Magazine

More News

  • CCI slaps over Rs 6,700 crore fine on 11 cement companies CCI slaps Rs 6,700-crore fine on 11 cement firms
  • Cotton and tusser products by women weave at the exhibition Mixed bag for Aditya Birla Retail
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard